Linsitinib
id:
linsitinib-255-11180265
title:
Linsitinib
text:
Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis. Linsitinib was granted orphan drug designation for adrenocortical carcinoma in March 2012. Phase II clinical trials were initiated for multiple myeloma, ovarian cancer, hepatocellular carcinoma, and NSCLC, but subsatisfactory results
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Linsitinib
date created:
date modified:
2021-11-16T00:53:57Z
main entity:
{"identifier":"Q6554803","url":"https://www.wikidata.org/entity/Q6554803"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b9/Linsitinib.svg","width":512,"height":558}
fields total:
13
integrity:
15